Penserra Capital Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Penserra Capital Management’s Portfolio PEAR Stock Details PEAR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$5K	Sell
2022 Q1	$23K	Sell
2021 Q4	$37K	Buy